Feedback / Questions
RhuDex (AV 1142742) - Active Biotech, Dr Falk, Medigene
Medigene: Corporate Presentation
(MediGene Press Release)
-
Jun 14, 2013 -
Anticipated data from P2 trial for primary biliary cirrhosis by end of 2015
Anticipated P2 data
•
Immunology
http://www.medigene.com/sites/default/files/downloads/20130611_corppresentation_june2013_2_0.pdf
Jun 14, 2013
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
.